Viagra Professional Sublingual

pmid:15509203, doi:10.1111/j.1442-2042.2004.00933.x, clinical trial, randomized controlled trial, serkan deveci, levent peşkircioğlu, hakan ozkardeş, 3',5'-cyclic-gmp phosphodiesterases / antagonists & inhibitors, administration, sublingual, adult, aged, dose-response relationship, drug, erectile dysfunction / drug therapy*, flushing / chemically induced, headache / chemically induced, humans, male, middle aged, phosphodiesterase inhibitors / administration & dosage*, phosphodiesterase inhibitors / adverse effects, piperazines / administration & dosage*, piperazines / adverse effects, purines, sildenafil citrate, sulfones, sweating, treatment outcome, pubmed abstract, nih, nlm, ncbi, national institutes of health, national center for biotechnology information, national library of medicine, medline